FEMS Microbiology Letters · 1998 · 345 citations · 16 references
Life SciencesMicrobiologyMolecular BiologyAntimicrobial ResistanceEnzymologyMicrobial GeneticsAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsEfflux-mediated ResistanceMultidrug ResistanceResistance GenesBacterial Multidrug ResistanceCell LysisCell Lysis KineticsEscherichia ColiEscherichia Coli ResistanceLipid Biosynthesis RegulationMultidrug Resistance Mechanisms
Triclosan (Irgasan) is a broad spectrum antimicrobial agent used in handsoaps, toothpastes, fabrics, and plastics. It inhibits lipid biosynthesis in Escherichia coli, probably by action upon enoyl reductase (FabI) (McMurry, L.M., Oethinger, M. and Levy, S.B. (1988) Nature 394, 531-532). We report here that overexpression of the multidrug efflux pump locus acrAB, or of marA or soxS, both encoding positive regulators of acrAB, decreased susceptibility to triclosan 2-fold. Deletion of the acrAB locus increased the susceptibility to triclosan approximately 10-fold. Four of five clinical E. coli strains which overexpressed marA or soxS also showed enhanced triclosan resistance. The acrAB locus was involved in the effects of triclosan upon both cell growth rate and cell lysis.
16
Triclosan: Applications and safety
Hridaya N. Bhargava, Patricia A. Leonard · American Journal of Infection Control · 1996 · 528 citations
Active efflux of bile salts by Escherichia coli
David G. Thanassi, Lu Cheng, Hiroshi Nikaido · Journal of Bacteriology · 1997 · 473 citations